Ignite Creation Date:
2024-05-06 @ 3:42 PM
Last Modification Date:
2024-10-26 @ 1:54 PM
Study NCT ID:
NCT04723537
Status:
TERMINATED
Last Update Posted:
2024-06-06
First Post:
2021-01-18
Brief Title:
Upamostat a Serine Protease Inhibitor or Placebo for Treatment of COVID-19 Disease
Sponsor:
RedHill Biopharma Limited
Organization:
RedHill Biopharma Limited
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-02-16
Start Date Type:
ACTUAL
Primary Completion Date:
2021-12-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-12-28
Completion Date Type:
ACTUAL
First Submit Date:
2021-01-18
First Submit QC Date:
January 21 2021
Study First Post Date:
2021-01-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2024-06-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-07
Last Update Post Date:
2024-06-06
Last Update Post Date Type:
ACTUAL